摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-溴-4'-甲基苯丙酮 | 1451-82-7

中文名称
2-溴-4'-甲基苯丙酮
中文别名
2-溴-4’-甲基苯丙酮;2-溴-4-甲基苯丙酮
英文名称
2-bromo-4'-methylpropiophenone
英文别名
2-bromo-1-(p-tolyl)propan-1-one;α-bromo-p-methylpropiophenone;2-bromo-1-(4-methylphenyl)propan-1-one;1-(4-methylphenyl)-1-oxo-2-bromopropane
2-溴-4'-甲基苯丙酮化学式
CAS
1451-82-7
化学式
C10H11BrO
mdl
MFCD11131402
分子量
227.101
InChiKey
OZLUPIIIHOOPNQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    12
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    17.1
  • 氢给体数:
    0
  • 氢受体数:
    1

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    Phase I metabolites of mephedrone display biological activity as substrates at monoamine transporters
    摘要:
    Background and Purpose4‐Methyl‐N‐methylcathinone (mephedrone) is a synthetic stimulant that acts as a substrate‐type releaser at transporters for dopamine (DAT), noradrenaline (NET) and 5‐HT (SERT). Upon systemic administration, mephedrone is metabolized to several phase I compounds: the N‐demethylated metabolite, 4‐methylcathinone (nor‐mephedrone); the ring‐hydroxylated metabolite, 4‐hydroxytolylmephedrone (4‐OH‐mephedrone); and the reduced keto‐metabolite, dihydromephedrone.Experimental ApproachWe used in vitro assays to compare the effects of mephedrone and synthetically prepared metabolites on transporter‐mediated uptake and release in HEK293 cells expressing human monoamine transporters and in rat brain synaptosomes. In vivo microdialysis was employed to examine the effects of i.v. metabolite injection (1 and 3 mg·kg−1) on extracellular dopamine and 5‐HT levels in rat nucleus accumbens.Key ResultsIn cells expressing transporters, mephedrone and its metabolites inhibited uptake, although dihydromephedrone was weak overall. In cells and synaptosomes, nor‐mephedrone and 4‐OH‐mephedrone served as transportable substrates, inducing release via monoamine transporters. When administered to rats, mephedrone and nor‐mephedrone produced elevations in extracellular dopamine and 5‐HT, whereas 4‐OH‐mephedrone did not. Mephedrone and nor‐mephedrone, but not 4‐OH‐mephedrone, induced locomotor activity.Conclusions and ImplicationsOur results demonstrate that phase I metabolites of mephedrone are transporter substrates (i.e. releasers) at DAT, NET and SERT, but dihydromephedrone is weak in this regard. When administered in vivo, nor‐mephedrone increases extracellular dopamine and 5‐HT in the brain whereas 4‐OH‐mephedrone does not, suggesting the latter metabolite does not penetrate the blood–brain barrier. Future studies should examine the pharmacokinetics of nor‐mephedrone to determine its possible contribution to the in vivo effects produced by mephedrone.
    DOI:
    10.1111/bph.13547
  • 作为产物:
    描述:
    3-(dimethylamino)-2-methyl-1-(p-tolyl)prop-2-en-1-one氢溴酸 作用下, 以 乙腈 为溶剂, 反应 3.0h, 以53%的产率得到2-溴-4'-甲基苯丙酮
    参考文献:
    名称:
    Access to α,α-dihaloacetophenones through anodic C C bond cleavage in enaminones
    摘要:
    DOI:
    10.1016/j.tetlet.2021.153575
点击查看最新优质反应信息

文献信息

  • Stereodivergent Synthesis of Chromanones and Flavanones via Intramolecular Benzoin Reaction
    作者:Genfa Wen、Yingpeng Su、Guoxiang Zhang、Qiqiao Lin、Yujin Zhu、Qianqian Zhang、Xinqiang Fang
    DOI:10.1021/acs.orglett.6b01767
    日期:2016.8.19
    The strategy of stereodivergent reactions on racemic mixtures (stereodivergent RRM) was employed for the first time in intramolecular benzoin reactions and led to the rapid access of chromanones/flavanones with two consecutive stereocenters. The easily separable stereoisomers of the products were obtained with moderate to excellent enantioselectivities in a single step. Catechol type additives proved
    外消旋混合物的立体发散反应策略(立体发散的RRM)是首次在分子内安息香反应中采用,并导致色酮/黄酮与两个连续的立体中心快速接触。一步即可获得具有中等至优异对映选择性的产品易分离的立体异构体。邻苯二酚型添加剂被证明对实现所需的非对映选择性和对映选择性至关重要。
  • Reduction of Aromatic α-Halo Ketones with Metallic Bismuth
    作者:Ping-Da Ren、Qi-Hui Jin、Zi-Peng Yao
    DOI:10.1080/00397919708004126
    日期:1997.8
    Abstract Aromatic α-bromo ketones and α-iodio ketones can be reduced by bismuth prepared from NaBH4 and BiCl3 in water to their parent ketones in high yields, but aromatic α-chloro ketones should be added to sodium iodide first.
    摘要 由NaBH4和BiCl3中制备的可以将芳香α-酮和α-酮以高产率还原为其母酮,但芳香α-氯酮应先加入碘化钠中。
  • Cobalt-Catalyzed Reductive C–O Bond Cleavage of Lignin β-O-4 Ketone Models via In Situ Generation of the Cobalt–Boryl Species
    作者:Kecheng Gao、Man Xu、Cheng Cai、Yanghao Ding、Jianhui Chen、Bosheng Liu、Yuanzhi Xia
    DOI:10.1021/acs.orglett.0c02117
    日期:2020.8.7
    An efficient and mild method for reductive C–O bond cleavage of lignin β-O-4 ketone models was developed to afford the corresponding ketones and phenols with PDI-CoCl2 as the precatalyst and diboron reagent as the reductant. The synthetic utility of the methodology was demonstrated by depolymerization of a polymeric model and gram-scale transformation. Mechanistic studies suggested that this transformation
    开发了一种有效且温和的方法来还原木质素β-O-4酮模型的C-O键断裂,以PDI -CoCl 2为前催化剂和以二硼试剂为还原剂提供相应的酮和苯酚。该方法的合成效用通过聚合物模型的解聚和克级转化得以证明。机理研究表明,这种转化涉及羰基插入,1,2-布鲁克型重排,β-氧消除和催化活性Co-B物种限速再生的步骤。
  • Modulators Of HEC1 Activity And Methods Therefor
    申请人:Lau Johnson
    公开号:US20110230486A1
    公开(公告)日:2011-09-22
    Compounds, compositions, and methods for modulation of Hec1/Nek2 interaction are provided. Especially preferred compounds disrupt Nek2/Hec1 binding and are therefore useful as chemotherapeutic agent for neoplastic diseases.
    提供了用于调节Hec1/Nek2相互作用的化合物、组合物和方法。特别偏爱的化合物会破坏Nek2/Hec1的结合,因此可用作肿瘤疾病的化疗药物。
  • [EN] IMPROVED MODULATORS OF HEC1 ACTIVITY AND METHODS THEREFOR<br/>[FR] MODULATEURS AMÉLIORÉS DE L'ACTIVITÉ HEC1 ET PROCÉDÉS ASSOCIÉS
    申请人:TAIVEX THERAPEUTICS CORP
    公开号:WO2013082324A1
    公开(公告)日:2013-06-06
    Compounds, compositions, and methods for modulation of Hec1/Nek2 interaction are provided. Such compounds disrupt Nek2/Hec1 binding and may be useful as chemotherapeutic agents for neoplastic diseases.
    提供了用于调节Hec1/Nek2相互作用的化合物、组合物和方法。这些化合物破坏了Nek2/Hec1的结合,并可能作为抗肿瘤疾病的化疗药物有用。
查看更多